Official SEC submissions

Innate Pharma SEC Filings

Direct answer

Innate Pharma's latest SEC filing is 6-K.

It was filed on September 2, 2026, and 40 recent filings are available.
Each row links directly to the SEC document and filing index.
Official SEC EDGAR submissions

Get free Innate Pharma email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Recent SEC filings

6-K

Current report

Filed:

Report date:

6-K

Open SEC documentView filing index

6-K

Current report

Filed:

Report date:

6-K

Open SEC documentView filing index

6-K

Current report

Filed:

Report date:

6-K

Open SEC documentView filing index

6-K

Current report

Filed:

Report date:

6-K

Open SEC documentView filing index

6-K

Current report

Filed:

Report date:

6-K

Open SEC documentView filing index

6-K

Current report

Filed:

Report date:

6-K

Open SEC documentView filing index

6-K

Current report

Filed:

Report date:

6-K

Open SEC documentView filing index

6-K

Current report

Filed:

Report date:

6-K

Open SEC documentView filing index

6-K

Current report

Filed:

Report date:

6-K

Open SEC documentView filing index

6-K

Current report

Filed:

Report date:

6-K

Open SEC documentView filing index

6-K

Current report

Filed:

Report date:

6-K

Open SEC documentView filing index

6-K

Current report

Filed:

Report date:

6-K

Open SEC documentView filing index

6-K

Current report

Filed:

Report date:

6-K

Open SEC documentView filing index

6-K

Current report

Filed:

Report date:

6-K

Open SEC documentView filing index

6-K

Current report

Filed:

Report date:

6-K

Open SEC documentView filing index

6-K

Current report

Filed:

Report date:

6-K

Open SEC documentView filing index

6-K

Current report

Filed:

Report date:

6-K

Open SEC documentView filing index

6-K

Current report

Filed:

Report date:

6-K

Open SEC documentView filing index

20-F

Periodic report

Filed:

Report date:

20-F

Open SEC documentView filing index

6-K

Current report

Filed:

Report date:

6-K

Open SEC documentView filing index

6-K

Current report

Filed:

Report date:

6-K

Open SEC documentView filing index

6-K

Current report

Filed:

Report date:

6-K

Open SEC documentView filing index

6-K

Current report

Filed:

Report date:

6-K

Open SEC documentView filing index

6-K

Current report

Filed:

Report date:

6-K

Open SEC documentView filing index

6-K

Current report

Filed:

Report date:

6-K

Open SEC documentView filing index

6-K

Current report

Filed:

Report date:

6-K

Open SEC documentView filing index

6-K

Current report

Filed:

Report date:

6-K

Open SEC documentView filing index

6-K

Current report

Filed:

Report date:

6-K

Open SEC documentView filing index

6-K

Current report

Filed:

Report date:

6-K

Open SEC documentView filing index

6-K

Current report

Filed:

Report date:

6-K

Open SEC documentView filing index

6-K

Current report

Filed:

Report date:

6-K

Open SEC documentView filing index

6-K

Current report

Filed:

Report date:

6-K

Open SEC documentView filing index

6-K

Current report

Filed:

Report date:

6-K

Open SEC documentView filing index

6-K

Current report

Filed:

Report date:

6-K

Open SEC documentView filing index

6-K

Current report

Filed:

Report date:

6-K

Open SEC documentView filing index

6-K

Current report

Filed:

Report date:

6-K

Open SEC documentView filing index

6-K

Current report

Filed:

Report date:

6-K

Open SEC documentView filing index

6-K

Current report

Filed:

Report date:

6-K

Open SEC documentView filing index

6-K

Current report

Filed:

Report date:

6-K

Open SEC documentView filing index

6-K

Current report

Filed:

Report date:

6-K

Open SEC documentView filing index

Verified data

Recent filing categories
2
Recent filings
40
SEC CIK
0001598599
Latest filing date
September 2, 2026

Explore related company data

View the Innate Pharma company profileView Innate Pharma annual financials